ID
16701
Description
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Long-Term Follow-Up Assessment
Link
https://clinicaltrials.gov/ct2/show/NCT00373425
Keywords
Versions (1)
- 8/1/16 8/1/16 -
Uploaded on
August 1, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Long-Term Follow-Up Assessment, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Long-Term Follow-Up Assessment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Description
Radiology
Description
Chest/upper abdomen CT scan
Data type
integer
Alias
- UMLS CUI [1]
- C0202823
- UMLS CUI [2]
- C1627748
Description
Date chest/upper abdomen CT scan
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0202823
- UMLS CUI [2,1]
- C0011008
- UMLS CUI [2,2]
- C1627748
Description
If relapse was documented, complete Relapse Report and New Lesion Specification page.
Data type
boolean
Alias
- UMLS CUI [1]
- C0277556
Description
Radiologic Examination
Data type
boolean
Alias
- UMLS CUI [1]
- C0043299
Description
Date of assessment
Data type
date
Alias
- UMLS CUI [1]
- C2985720
Description
Evaluation Method
Data type
text
Alias
- UMLS CUI [1]
- C2911685
Description
If relapse was documented, complete Relapse Report and New Lesion Specification page.
Data type
boolean
Alias
- UMLS CUI [1]
- C0277556
Description
Chest X-ray
Data type
boolean
Alias
- UMLS CUI [1]
- C0039985
Description
Chest CT
Data type
boolean
Alias
- UMLS CUI [1]
- C0202823
Description
CT of the chest/upper abdomen
Data type
boolean
Alias
- UMLS CUI [1]
- C0202823
- UMLS CUI [2]
- C1627748
Description
Long-Term Follow-Up Adverse Events
Description
Long-Term Follow-Up Adverse Events
Description
Record only study drug-related events that are ongoing or new.
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
Grade severity (1,2,3,4,5) using NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0. A change in CTC grade should be recorded as a separate event.
Data type
integer
Alias
- UMLS CUI [1]
- C1710066
Description
Adverse Event Start Date
Data type
date
Alias
- UMLS CUI [1]
- C2697888
Description
Adverse Event End Date
Data type
date
Alias
- UMLS CUI [1]
- C2697886
Description
If event is serious, complete the SERIOUS ADVERSE EVENT FORM and fax to the appropriate number on the CRF General lnstructions page.
Data type
boolean
Alias
- UMLS CUI [1]
- C1710056
Similar models
Long-Term Follow-Up Assessment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0750480 (UMLS CUI [1,2])
C1522577 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,2])
C1627748 (UMLS CUI [2])
C0202823 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C1627748 (UMLS CUI [2,2])
C1627748 (UMLS CUI [2])